舒血宁注射液结合微创穿刺抽吸术治疗高血压性脑出血48例临床观察

Clinical Study on Treatment of Minimally Invasive Surgery Combined with Shuxuening Injection for 48 Cases of Intracranial Hematoma Caused by Hypertension Cerebral Hemorrhage

目的探讨舒血宁注射液结合微创穿刺抽吸术治疗高血压性脑出血的临床疗效。方法将48例病人随机分为治疗组和对照组,治疗组在微创治疗及内科常规治疗的基础上于术后72 h予舒血宁20 ml加入生理盐水250 ml静脉滴注,1次/d,共2周,对照组微创治疗及内科常规治疗。结果两组治疗均能改善患者临床症状,但治疗组基本痊愈率明显提高,而死亡率显著降低。结论舒血宁结合微创穿刺抽吸术治疗高血压性脑出血疗效优于单纯西医对照组。

Objective To study the therapeutic efficacy of minimally invasive surgery combined with Shuxuening injection for intracranial hematoma caused by hypertension cerebral hemorrhage. Methods 48 cases of ICH caused by hypertension cerebral hemorrhage were divided randomly into two groups. The control group （24） was treated by minimally invasive surgery combined with conventional medical treatment , and the treatment group was treated by Shuxuening injection combined with minimally invasive surgery and conventional medical treatment, the course of treatment was 2 weeks for each group. Results The two groups could improve the clinical symptomes of the patients but the basic curative rate in the treatment group was significantly higher than that （33.3%） in the control group（ 12.5 ） （ P 〈 0. 05 ）, and the rate of death significantly decreased. Conclusion The Shuxuening injection that in minimally invasive surgery for intracranial hematoma caused by hypertension cerebral hemorrhage efficacy was higher than combined with that in simple western Medicine group.